As shown in Fig. 1 most breast and endometrial cancer patients displayed upregulation of leupaxin expression in the tumour as compared to the normal tissue, whereas in lung cancer patients downregulation of leupaxin expression was clearly observed. Here, LPXN is linked to lung carcinoma.